Skip To Content
Opioid Overdose Education and Naloxone Administration Training is a Course

Opioid Overdose Education and Naloxone Administration Training

Ended Feb 8, 2021
1.5 credits

Full course description

In order to impact the community morbidity and mortality associated with the opioid crisis, and specifically to impact the number of fatal opioid overdoses in the community, the Texas A&M Rangel College of Pharmacy in collaboration with the Texas A&M Opioid Task Force proposes a program to provide credible and evidence-based information in the form of the Texas A&M Opioid Overdose Education and Naloxone Administration (OENA) training using a cadre pharmacy students that have identified that they have an interest in harm reduction, opioid use disorder, and educating the community in this life-saving action plan.

Objectives

At the conclusion of this activity, learners will be able to:

- Examine basic opioid pharmacology

- Examine opioid overdose rates and the opioid crisis

- Describe the role of naloxone in opioid overdose prevention

- Identify common risk factors for opioid overdose

- Recognize signs and symptoms of acute opioid overdose

- Describe the Opioid Overdose Prevention Action Plan

CCREDITATION

Texas A&M University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION

Texas A&M University College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The presentation titled, ā€œOpioid Overdose Education and Naloxone Administration Trainingā€ has been designated by the Texas A&M University College of Medicine for 1.5 hours of education in medical ethics and professional responsibility.

FACULTY DISCLOSURE

The faculty does not have a financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

PLANNERS DISCLOSURES

The planners do not have a financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.